Who owns CNS PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cns Pharmaceuticals stock

Who bought or sold CNS PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Armistice Capital 471k $171k 100% Mar 2024
 View chart
Citadel Advisors 91k $33k 100% Mar 2024
 View chart
Smith Anglin Financial 90k $33k 81% Mar 2024
 View chart
Vanguard Group 58k $21k 0% Mar 2024
 View chart
Geode Capital Management 28k $10k 16% Mar 2024
 View chart
Jane Street 27k $9.9k 100% Mar 2024
 View chart
Hrt Financial 22k $7.0k 100% Mar 2024
 View chart
Two Sigma Securities 22k $7.9k 100% Mar 2024
 View chart
XTX Topco 19k $6.8k 100% Mar 2024
 View chart
Virtu Financial 13k $17k 100% Dec 2023
 View chart
Tower Research Capital 6.8k $2.5k 43% Mar 2024
 View chart
Bank of America Corporation 779.00 $0 77800% Mar 2024
 View chart
Wells Fargo & Company 241.00 $87.627600 16% Mar 2024
 View chart
Morgan Stanley 67.00 $23.999400 0% Mar 2024
 View chart
Global Retirement Partners 53.00 $19.000500 0% Mar 2024
 View chart
FMR 14.00 $4.999400 100% Mar 2024
 View chart
Plante Moran Financial Advisors 1.00 $0 0% Mar 2024
 View chart

Who sold out of Cns Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2023 21k $24k